Article information
Full text is only aviable in PDF
REFERENCES
[1]
DA Holaday, AM Langer, W Nicholson, A Rohl.
Historical background.
Asbestos and disease,
[4]
JC Wagner, CA Sleggs, P Marchand.
Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.
Br J Ind Med, 17 (1960), pp. 260
[5]
M Greenberg.
Biological effects of asbestos: New York Academy of Sciences 1964.
Am J Ind Med, 43 (2003), pp. 543-552
[6]
M Greenberg.
Cape asbestos, barking, health and environment: 1928-1946.
Am J Ind Med, 43 (2003), pp. 109-119
[7]
T Kauppinen, J Toikkanen, D Pedersen, R Young, W Ahrens, P Boffetta, et al.
Occupational exposure to carcinogens in the European Union.
Occup Environ Med, 57 (2000), pp. 10-18
[8]
J Leigh, P Davidson, L Hendrie, D Berry.
Malignant mesothelioma in Australia, 1945-2000.
Am J Ind Med, 41 (2002), pp. 188-201
[9]
J Peto, JT Hodgson, FE Matthews, et al.
Continuing increase in mesothelioma mortality in Britain.
Lancet, 345 (1995), pp. 535-539
[10]
S Mattioli, D Nini, G Manzini, FS Violante.
Past asbestos exposure levels in foundries and cement-asbestos factories.
Am J Med, 34 (1998), pp. 197-201
[11]
M Erdinc, E Endrinc, G Cok, M Polatli.
Respiratory impairment due to asbestos exposure in brake-lining workers.
Environ Res, 91 (2003), pp. 151-153
[12]
WN Rom, SR Amar, S Hoffman.
Malignant mesothelioma from neighborhood exposure to anthophyllite asbestos.
Am J Ind Med, 40 (2001), pp. 211-214
[14]
A Churg.
Deposition and clearance of chrysotile asbestos.
Ann Occup Hyg, 38 (1994), pp. 625-633
[16]
Y Suzuki, N Kohyama.
Translocation of inhaled asbestos fibers from the lung to others tissues.
Am J Ind Med, 19 (1992), pp. 701-704
[17]
P Sebastien, X Janson, A Gaudichet.
Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura.
Biological effects of mineral fibres, pp. 237-246
[18]
R Begin, JW Christman.
Detailed occupational history: the cornerstone in the diagnosis of asbestos-related lung disease.
Am J Respir Crit Care Med, 163 (2001), pp. 705-710
[19]
A Churg, ML Warnock.
Analysis of the cores of ferruginous asbestos bodies from the general population. II. True asbestos bodies and pseudoasbestos bodies.
Lab Invest, 40 (1979), pp. 31-38
[20]
A Churg, ML Warnock.
Analysis of the cores of ferruginous asbestos bodies from the general population. III. Patients with environmental exposure.
Lab Invest, 40 (1979), pp. 622-626
[21]
A Churg.
Fiber counting and analysis of the diagnosis of asbestos related disease.
Hum Pathol, 14 (1982), pp. 381-392
[22]
IJ Selikoff, WJ Nicholson, AM Langer.
Asbestos air pollution.
Arch Environ Health, 25 (1972), pp. 1-4
[23]
VL Roggli, SD Greenberg, JL McLarty, GA Hurts, LR Hieger, ML Farley, et al.
Comparison of sputum and lung asbestos body counts in former asbestos workers.
Am Rev Respir Dis, 122 (1980), pp. 941-945
[24]
R Pifarré, E Monsó, A Rosell, M Llatjós, I Badorrey, J Morera.
Identificación de cuerpos de asbestos en el lavado broncoalveolar.
Arch Bronconeumol, 35 (1999), pp. 113-116
[25]
P de Vuyst, P Dumortier, E Moulin, N Yourassowsky, P Roomans, P de Francquen, et al.
Asbestos bodies in bronchoalveolar lavage reflect lung asbestos body concentration.
Eur Respir J, 1 (1988), pp. 362-367
[26]
P Sebastien, B Armstrong, G Monchaux, J Bignon.
Asbestos bodies in bronchoalveolar lavage fluid in lung parenchyma.
Am Rev Respir Dis, 137 (1988), pp. 75-78
[27]
P de Vuyst, J Jedwab, P Dumortier, G Vandermoten, R Vande Weyer, JC Yernault.
Asbestos bodies in bronchoalveolar lavage.
Am Rev Respir Dis, 126 (1982), pp. 972-976
[28]
J Bignon, P Sebastien, A Gaudichet, M Bientz.
Analysis of mineral particles recovered by bronchoalveolar lavage for diagnosis of dust related lung diseases.
Am Rev Respir Dis, 117 (1978), pp. A218
[29]
A Karjalainen, R Piipari, T Mäntylä, M Mönkkönen, M Nurminen, P Tukiainen, et al.
Asbestos bodies in bronchoalveolar lavage in relation to asbestos bodies and asbestos fibres in lung parenchyma.
Eur Respir J, 9 (1996), pp. 1000-1005
[30]
FD Pooley, DL Ranson.
Comparison of the results of asbestos fibre dust counts in lung tissue obtained by analytical electron microscopy and light microscopy.
J Clin Pathol, 39 (1986), pp. 313-317
[31]
P de Vuyst, A Karjalainen, P Dumortier, JC Pairon, E Monsó, P Brochard, et al.
Guidelines for mineral fibre analysis in biological samples: Report of the ERS Working Group.
Eur Respir J, 11 (1998), pp. 1416-1426
[32]
RF Dodson, D Greenberg, MG Williams, CJ Corn, MF O'Sullivan, GA Hurst.
Asbestos content in lungs of occupationally and nonoccupationally exposed individuals.
JAMA, 252 (1984), pp. 68-71
[33]
A Churg, ML Warnock.
Correlation of quantitative asbestos body counts and occupation in urban patients.
Arch Pathol Lab Med, 101 (1977), pp. 629-634
[34]
BW Case, P Sebastien, CJ McDonald.
Lung fiber analysis in accident victims: a biological assessment of general environment exposures.
Arch Environ Health, 43 (1988), pp. 178-179
[35]
E Monsó, A Texidó, D López, X Aguilar, J Fiz, J Ruiz, et al.
Asbestos bodies in normal lung of Western Mediterranean populations with no occupational exposure to inorganic dust.
Ach Environ Health, 50 (1995), pp. 305-311
[36]
FD Pooley.
Asbestos bodies: their formation, composition and character.
Environ Res, 5 (1972), pp. 363-379
[37]
E Monsó, JM Tura, J Pujadas, F Morell, J Ruiz, J Morera.
Lung dust content in idiopathic pulmonary fibrosis: a study with scanning electron microscopy and energy dispersive x ray analysis.
Br J Ind Med, 48 (1991), pp. 327-331
[38]
E Moulin, N Yourassowsky, P Dumortier, P de Vuyst, JC Yernault.
Electron microscopic analysis of asbestos body cores from the Belgian urban population.
Eur Respir J, 1 (1988), pp. 818-822
[39]
VL Kinnula.
Oxidant and antioxidant mechanism of lung disease caused by asbestos fibres.
Eur Respir J, 14 (1999), pp. 706-716
[40]
W Rom, WD Travis, AR Brody.
Cellular and molecular basis of the asbestos related diseases.
Am Rev Respir Dis, 143 (1991), pp. 408-422
[41]
G Hillerdal.
Asbestos-related pleural disease including diffuse malignant mesothelioma.
Eur Respir Mon, 22 (2002), pp. 189-203
[42]
G Hillerdal.
Pleural plaques and risk for bronchial carcinoma and mesothelioma. Aprospective study.
Chest, 105 (1994), pp. 144-150
[43]
J van Cleemput, H de Raeve, JA Verschakelen, J Rombouts, LM Lacquet, B Nemery.
Surface of localized pleural plaques quantitated by computed tomography scanning: no relation with cumulative asbestos exposure and no effect on lung function.
Am J Respir Crit Care Med, 163 (2001), pp. 598-599
[44]
A Karjalainen, PJ Karhunen, K Lalv.
Pleural plaques and exposure to mineral fibres in a male urban necropsy population.
Occup Environ Med, 51 (1994), pp. 456-460
[45]
J van Cleemput, H de Raeve, JA Verschakelen, J Rombouts, LM Lacquet, B Nemery.
Surface of localized pleural plaques quantitated by computed tomography scanning: no relation with cumulative asbestos exposure and no effect on lung function.
Am J Respir Crit Care, 163 (2001), pp. 598-599
[46]
M Stephens, AR Gibbs, FD Pooley, JC Wagner.
Asbestos induced diffuse pleural fibrosis: pathology and mineralogy.
Thorax, 42 (1987), pp. 583-588
[47]
International Labour Office.
Guidelines for the use of International Classification Radiographs of Pneumoconioses. Revised edition 1980, Occupational Safety and Health Series 22, (1980),
[48]
G Hillerdal.
Pleural lesions and the ILO classification: the need for a revision.
Am J Ind Med, 19 (1991), pp. 125-130
[49]
M Tiitola, L Kivisaari, A Zitting, MS Huuskonen, S Kaleva, A Tossavainen, et al.
Computed tomography of asbestos-related pleural abnormalities.
Arch Occup Environ Health, 75 (2002), pp. 224-228
[50]
J Bourbeau, P Ernst, J Chrome, et al.
The relationship between respiratory impairment and asbestos related pleural abnormality in an active work force.
Am Rev Respir Dis, 142 (1999), pp. 837
[51]
RF Sison, RH Hruban, WG Moore, JE Kulman, PS Wheller, GM Hutchins.
Pulmonary diseases associated with pleural "asbestos" plaques.
Chest, 95 (1989), pp. 831-835
[53]
GR Epler, TC McLoud, EA Gaensler.
Prevalence and incidence of benign asbestos pleural effusion in a working population.
JAMA, 247 (1982), pp. 617
[54]
M Metintas, I Ucgun, O Elbek, S Erginel, SA Metintas, M Kolsuz, et al.
Computed tomography features in malignant mesothelioma and other commonly seen pleural diseases.
Eur J Radiol, 41 (2002), pp. 1-9
[55]
DA Schwartz.
New developments in asbestos induced pleural disease.
Chest, 99 (1991), pp. 191-198
[57]
American Thoracic Society.
The diagnosis of non-malignant diseases related to asbestos.
Am Rev Respir Dis, 134 (1986), pp. 363-368
[58]
R Begin, A Cantin, S Mase.
Recent advances in the clinical assessment and pathogenesis of the mineral dust pneumoconioses.
Eur Respir J, 2 (1989), pp. 988-1001
[59]
BT Mossman, A Churg.
Mechanisms in the pathogenesis of asbestosis and silicosis.
Am J Respir Crit Care Med, 157 (1998), pp. 1666-1680
[60]
JE Craighead, JL Abraham, A Churg, et al.
The pathology of asbestos associated diseases of the lung and pleural cavities: diagnostic criteria and proposed grading scheme.
Arch Pathol Lab Invest, 106 (1982), pp. 544-595
[61]
R Bégin, G Ostiguy, R Filion, et al.
Computed tomography in the early detection of asbestosis.
Br J Ind Med, 50 (1993), pp. 689-698
[62]
M Akira.
High-resolution CT in the evaluation of occupational and environmental disease.
Radiol Clin North Am, 40 (2002), pp. 43-59
[63]
W Morgan, JB Gee.
Asbestos-related diseases.
Occupational lung diseases, 3rd ed., pp. 318-325
[64]
R Begin.
Asbestos related diseases.
Eur Respir Mon, 11 (1999), pp. 1158-1177
[65]
W Weiss.
Asbestosis: a marker for increased risk of lung cancer among workers exposed to asbestos.
Chest, 115 (1999), pp. 536-549
[66]
International Agency for Research on Cancer.
Overall evaluations of carcinogenicity: an Updating of I ARC Monographs Volumes, IARC, (1987),
[67]
R Begin, JJ Gauthier, M Desmeules, G Ostiguy.
Work related mesothelioma in Quebec 1967-1990.
Am J Ind Med, 22 (1992), pp. 531-542
[68]
DH Yates, B Corrin, PN Stildolph, et al.
Malignant mesothelioma in South East England: clinicopathological experience of 272 cases.
Thorax, 45 (1997), pp. 124-135
[69]
A Agudo, C González, MJ Bleda, J Ramírez, S Hernández, F López, et al.
Occupation and risk of malignant pleural mesothelioma: a case-control study in Spain.
Am J Ind Med, 37 (2000), pp. 159-168
[70]
C Magnani, A Agudo, CA González, A Andrion, A Calleja, E Chellini, et al.
Multicentric study of non malignant pleural mesothelioma and non-occupational exposure to asbestos.
Brit J Cancer, 83 (2000), pp. 104-111
[71]
World Health Organization.
Chrysotile asbestos. Environmental Health Criteria 203, pp. 144
[72]
G Hillerdal.
Malignant mesothelioma 1982: review of 4710 published cases.
Br J Dis Chest, 77 (1983), pp. 321-343
[73]
T van Gelder, RA Damhuis, HC Hoogstedon.
Prognostic factors and survival in malignant pleural mesothelioma.
Eur Respir J, 7 (1994), pp. 1035-1038
[74]
CR McGavin, PD Hughes.
Finger clubbing in malignant mesothelioma and benign asbestos pleural disease.
Respir Med, 92 (1998), pp. 691-692
[75]
NG Ordóñez.
Value of Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.
Am J Clin Pathol, 109 (1998), pp. 85-89
[76]
International Mesothelioma Interest Group.
A proposed new international TNM staging system for malignant mesothelioma.
Chest, 108 (1995), pp. 1122-1128
[77]
SM Albelda.
Advances in the treatment of malignant pleural mesothelioma.
Chest, 116 (1999), pp. 504-520
[78]
DH Sterman, L Kaiser, SM Albelda.
Advances in the treatment of malignant pleural mesothelioma.
Chest, 116 (1999), pp. 504-520
[79]
SM Albelda.
Gene therapy for lung cancer and mesothelioma.
Chest, 111 (1997), pp. 144S-149S
[80]
WR Smythe.
Current therapy for malignant mesothelioma.
Curr Oncol Rep, 4 (2002), pp. 305-313
[81]
KM Lynch, WA Smith.
Pulmonary asbestosis. Carcinoma of lung in asbestos-silicosis.
Am J Cancer, 24 (1935), pp. 56
[82]
L Simonato, P Vineis, AC Fletcher.
Estimates of the proportion of lung cancer attributable to occupational exposure.
Carcinogenesis, 9 (1988), pp. 1159-1165
[83]
F Mollo, C Magnani, P Bo, P Burlo, M Cravello.
The attribution of lung cancers to asbestos exposure.
Am J Clin Pathol, 117 (2002), pp. 90-95
[84]
MI Badorrey, E Monso, A Teixido, R Pifarré, A Rosell, M Llatjos.
Frecuencia y riesgo de neoplasia broncopulmonar relacionada con asbestos.
Med Clin (Barc), 117 (2001), pp. 1-6
[85]
B Lee, JC Wain, KT Kelsey, JK Wiencke, DC Christiani.
Association of cigarette smoking and asbestos exposure with location and histology of lung cancer.
Am J Respir Crit Care Med, 157 (1998), pp. 748-755
[86]
MB Schabath, MR Spitz, GL Delclos, GB Gunn, LW Whitehead, X Wu.
Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes and lung cancer risk.
Am J Ind Med, 42 (2002), pp. 29-37
[87]
M Tiitola, L Kivisaari, MS Huuskonen, K Mattson, H Koskinen, H Lehtola, et al.
Computed tomography for lung cancer in asbestos-exposed workers.
Lung Cancer, 163 (2002), pp. 705-710
[88]
Fundación Laboral de la Construcción del Principado de Asturias.
Amianto y salud, Grupo Eujoa, (2001),
[89]
D Berrigan.
Respiratory cancer and exposure to man-made vitreous fibers: a systematic review.
Am J Ind Med, 42 (2002), pp. 354-362
[90]
C Paris, M Letourneux, P Catilina, P Friman, A Sobaszek, C Boutin.
Programmes de prevention chez les personnes exposées a l'amiante: bilan des experiences en cours.
Rev Mal Respir, 16 (1999), pp. 1332-1349
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
